Efficacy and Safety Study of Low-Dose Ondansetron For Adjunctive Therapy In Adult Patients With Obsessive-Compulsive Disorder
Clinical trial NCT01275248 · TERMINATED
Trial details
- NCT number
- NCT01275248
- Sponsor
- Transcept Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2015-09-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.